A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein

Yingzhu Chen^{1

2}, Shuai Lu², Hao Jia^{1

2}, Yao Deng², Jianfang Zhou², Baoying Huang², Yueyang Yu², Jiaming Lan², Wenling Wang², Yongliang Lou¹, Kun Qin², Wenjie Tan^{1

2}

Affiliations

¹ School of Laboratory Medicine and Life Science, Institute of Medical Virology, Wenzhou Medical University, Wenzhou 325035, China.
² Key Laboratory of Medical Virology, National Health and Family Planning Commission, National Institute for Viral Disease Control and Prevention, China CDC, Beijing 102206, China.

Published Erratum

Yingzhu Chen et al. Emerg Microbes Infect. 2017.

. 2017 Jun 28;6(6):e60.

doi: 10.1038/emi.2017.50.

Yingzhu Chen^{1

2}, Shuai Lu², Hao Jia^{1

2}, Yao Deng², Jianfang Zhou², Baoying Huang², Yueyang Yu², Jiaming Lan², Wenling Wang², Yongliang Lou¹, Kun Qin², Wenjie Tan^{1

2}

¹ School of Laboratory Medicine and Life Science, Institute of Medical Virology, Wenzhou Medical University, Wenzhou 325035, China.
² Key Laboratory of Medical Virology, National Health and Family Planning Commission, National Institute for Viral Disease Control and Prevention, China CDC, Beijing 102206, China.

Abstract

This corrects the article DOI: 10.1038/emi.2017.18.

A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein.
Chen Y, Lu S, Jia H, Deng Y, Zhou J, Huang B, Yu Y, Lan J, Wang W, Lou Y, Qin K, Tan W. Chen Y, et al. Emerg Microbes Infect. 2017 May 24;6(5):e37. doi: 10.1038/emi.2017.18. Emerg Microbes Infect. 2017. PMID: 28536429 Free PMC article.